A comprehensive view of hospital / clinical drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca, MSD report UK Medicines & Healthcare Regulatory Agency approves Lynparza Olaparib in combination with abiraterone and prednisone or prednisolone to treat metastatic castration-resistant prostate cancer
Published: March 20, 2023 by PharmaTimes
Pfizer and Astellas report Phase 3 study shows Xtandi enzalutamide plus leuprolide significantly improves metastasis-free survival in men with non-metastatic prostate cancer
Published: March 17, 2023 by Contify Life Science News
J&J and Legend Biotech will not launch CAR-T therapy Carvykti in UK at this time to treat heavily pretreated myeloma; Myeloma UK says issues with supply, demand for CAR-T therapies may have influenced J&J’s decision
Published: March 16, 2023 by FiercePharma
Emory University partners with Pfizer to develop potential antiviral compounds to treat COVID-19; at least 11 scientists and support staff from Emory to help in research, which will look in part into new treatments to combine with Pfizer’s Paxlovid
Published: March 14, 2023 by Atlanta Journal-Constitution (GA)
FDA lists albuterol sulfate inhalation solution as ‘in shortage’ after Akorn closes all of its manufacturing sites; closure leaves only one US manufacturer of albuterol sulfate inhalation solution used to treat asthma and other respiratory conditions
Published: March 07, 2023 by Daily Herald

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count